DSD-T226

Congenital adrenal hyperplasia (CAH) · 46,XY · DSD-T226

DSD-T226 · Congenital adrenal hyperplasia (CAH) · 2021 · Automated translation

Genes AR · Karyotype 46,XY

46,XX congenital adrenal hyperplasia due to P450 oxidoreductase deficiency (compound heterozygous POR variants), with primary amenorrhea and infertility.

Case fields and evidence

Category

Congenital adrenal hyperplasia (CAH)

Karyotype

46,XY

Genetics

AR

Diagnosis

46,XX congenital adrenal hyperplasia due to P450 oxidoreductase deficiency (compound heterozygous POR variants), with primary amenorrhea and infertility.

Follow-up

Cesarean section at 37 weeks + 2 days delivered a healthy boy and girl (twins).

General phenotype

Female phenotype, primary amenorrhea, immature sexual development; no clear description of genital ambiguity.

Imaging

Ovarian cysts; thin endometrium during the ovulation induction cycle (specific value not reported in the original article).

Laboratory findings

Elevated baseline serum progesterone and 17-OHP, low estradiol; during ovulation induction, follicular development was normal but E2 rise was limited and progesterone rose prematurely to luteal-phase levels; after dexamethasone suppression, baseline P decreased to <1.5 ng/mL.

Management

Dexamethasone 0.375 mg/day to suppress adrenal progesterone; IVF yielded 4 oocytes and 4 transferable embryos were cryopreserved; frozen-thawed embryo transfer after artificial endometrial preparation.

Pathology

Not reported in the original article

Evidence level

See source

Clinical history

See source

Growth and development

See source

Puberty / Tanner

See source

Limitations

See source

Cite this resource

DSD Research Library | Congenital adrenal hyperplasia (CAH) · 46,XY · DSD-T226 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-T226?version=v1.4.0